Ann: Phosphagenics ProPhase Arbitration Ruling Handed Down, page-84

Playez that is not the point I am making. The point I am making is you are putting forward a water soluble vitamin e versus a lipid based TPM. They are very different delivery systems in particular when you are attempting to deliver across a cell membrane. In your article ,it refers to topical applications but not any commercialized products (i may be wrong but that is how I interpret it). It is either capsule or liquid. This is vastly different to what TPM has already been able to deliver drugs via its method. So the point is you are not comparing the same things. also on the point of it being 'novel' it is not really the point. They have patents for their delivery system. In other industries, there are competitors who each claim to be better than each other. No difference in this situation the question is whether they can make money from them. TPM has claimed some impressive numbers in their latest patent. Lets see whether Terumo can make us money out of those numbers.